HRT Financial’s Oscar Health OSCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-377,963
Closed -$5.32M 4479
2025
Q4
$5.43M Sell
377,963
-1,140,680
-75% -$19.7M 0.02% 745
2025
Q3
$28.7M Buy
1,518,643
+976,125
+180% +$16.1M 0.11% 122
2025
Q2
$11.6M Buy
542,518
+509,096
+1,523% +$7.57M 0.05% 272
2025
Q1
$438K Buy
+33,422
New +$496K ﹤0.01% 1538
2024
Q2
Sell
-41,508
Closed -$617K 2861
2024
Q1
$617K Sell
41,508
-84,048
-67% -$1.15M ﹤0.01% 1145
2023
Q4
$1.15M Buy
+125,556
New +$866K 0.01% 922
2022
Q3
Sell
-612,169
Closed -$2.6M 3308
2022
Q2
$2.6M Buy
+612,169
New +$3.9M 0.03% 473
2021
Q4
Sell
-31,721
Closed -$551K 3832
2021
Q3
$551K Buy
+31,721
New +$538K ﹤0.01% 1891
2021
Q2
Sell
-64,834
Closed -$1.74M 3337
2021
Q1
$1.74M Buy
+64,834
New +$2.03M 0.02% 688

Other funds holding OSCR

HRT Financial's OSCR Position: Q1 2026 in Review

HRT Financial sold out of Oscar Health (OSCR) in Q1 2026, closing a stake of 377,963 shares — an estimated $5.32M sold.

HRT Financial first reported a position in OSCR in Q1 2021 and held it in 9 quarters. The position peaked at $28.7M in Q3 2025. 332 funds tracked by Wall St. Rank hold OSCR as of Q1 2026.

  • HRT Financial reported no remaining Oscar Health position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 377,963 Oscar Health shares in Q1 2026, an estimated $5.32M.
  • HRT Financial first reported a position in Oscar Health in Q1 2021 and held it in 9 quarters.
  • HRT Financial's Oscar Health position peaked at $28.7M in Q3 2025.
  • 332 funds tracked by Wall St. Rank held Oscar Health as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.